Textos Completos Autorizados

Diabetología
SIIC selecciona textos completos de calidad y de reciente publicación en fuentes prestigiosas del mundo indizadas por SIIC Data Bases, capturadas en las mismas colecciones o en diversas bases especializadas.
La creciente cantidad de artículos con Acceso Abierto (Open Access) amplía la oferta de lectura pero a su vez también, entre tanta abundancia, complica al lector en su encuentro con los estudios fundamentales. Para facilitarlo, profesionales biomédicos de SIIC consultan diariamente una profusa cantidad de documentos que nutrirán Textos completos autorizados (TCA).

Las citas de la sección TCA enlazan de manera legal, autorizada y gratuita con los textos completos (full text) publicados en los sitios oficiales de sus respectivas fuentes.

SIIC creó, produjo y opera con exclusividad el software TCA para la interpretación de los diversos campos documentales que integran la estructura de un estudio: especialidad, modalidad del estudio, fuente, fechas de publicación y selección, definición de la fuente, limitaciones de consulta, resumen en castellano, etc.

Si bien la mayoría de los textos seleccionados corresponden a artículos originales, revisiones y guías, los lectores también encontrarán comentarios, entrevistas, notas periodísticas, cartas a autores u otros textos precursores de debates o aclaratorios.

Con una o todas las palabras
(escribir en inglés)
 
Ej.1: Adipokines Ej.2: Adipokines or Musculoskeletal
Con la frase exacta
(inglés)

Ej.3: Adipokines and Cardiovascular Systems
Con todas de las palabras
(inglés)

Ej.4: Adipokines and Cardiovascular and Systems
Sin las palabras
(inglés)

Ej.5: not Cardiovascular Systems
BMC complementary medicine and therapies
Selección SIIC: 18 Abril, 2024
BMC complementary medicine and therapies

Ethnobotanical survey on herbal remedies for the management of type 2 diabetes in the Casablanca-Settat region, Morocco.

Ethnobotanical survey on herbal remedies for the management of type 2 diabetes in the Casablanca-Settat region, Morocco.

Fuente:Bmc Complementary Medicine and Therapies

Extracto: This research underscores the practicality of incorporating traditional medicine into the healthcare framework of the Casablanca-Settat region. The findings not only offer valuable documentation but also have a vital function in safeguarding knowledge regarding the utilization of medicinal plants in this locality. Moreover, they provide opportunities to delve deeper into the phytochemical and pharmacological potential of these plants.

Claves:Casablanca-settat, Morocco, Ethnobotanical survey, Medicinal plants, Phytotherapy, Type 2 diabetes mellitus

Cita:BMC Complement Med Ther 2024 Apr 15; 24 (1) : 160.

Autor/es:Arraji, Maryem (a)
Al Wachami, Nadia (b)

institución:(a) Hassan First University of Settat, Higher Institute of Health Sciences, Laboratory of Sciences and Health Technologies, Settat, 26000, Morocco. m.arraji@uhp.ac.ma.
(b) Hassan First University of Settat, Higher Institute of Health Sciences, Laboratory of Sciences and Health Technologies, Settat, 26000, Morocco.

Conflicto:Los autores declaran no tener conflictos de interés con la investigación

Formato:Informe virtual

Idioma:Inglés

País de fuente:Reino Unido

Sitio web:http://dx.doi.org/10.1186/s12906-024-04468-4

Journal of Korean medical science
Selección SIIC: 18 Abril, 2024
Journal of Korean medical science

Antimicrobial Use and Carbapenem-Resistant Enterobacterales in Korea: A Nationwide Case-Control Study With Propensity Score Matching.

Antimicrobial Use and Carbapenem-Resistant Enterobacterales in Korea: A Nationwide Case-Control Study With Propensity Score Matching.

Fuente:Journal of Korean Medical Science

Extracto: The utilization of broad-spectrum antibiotics and the presence of comorbidities are associated with increasing development of CRE. This study emphasizes the importance of antimicrobial stewardship in reducing broad-spectrum antibiotic use and CRE disease burden in Korea.

Claves:Antimicrobial Stewardship, Carbapenemase, Carbapenems, Risk Factors

Cita:J Korean Med Sci 2024 Apr 15; 39 (14) : e132.

Autor/es:Kwon, Ki Tae (a)
Kim, Yoonjung (b)

institución:(a) Division of Infectious Diseases, Department of Internal Medicine, Kyungpook National University Hospital, Kyungpook National University School of Medicine, Daegu, Korea.
(b) Division of Infectious Diseases, Department of Internal Medicine, Kyungpook National University Hospital, Kyungpook National University School of Medicine, Daegu, Korea.

Conflicto:The authors have no potential conflicts of interest to disclose.

Formato:Informe virtual

Idioma:Inglés

País de fuente:Corea del Sur

Sitio web:http://dx.doi.org/10.3346/jkms.2024.39.e132

JAMA network open
Selección SIIC: 18 Abril, 2024
JAMA network open

Anti-Tumor Necrosis Factor Therapy and Risk of Kidney Function Decline and Mortality in Inflammatory Bowel Disease.

Anti-Tumor Necrosis Factor Therapy and Risk of Kidney Function Decline and Mortality in Inflammatory Bowel Disease.

Fuente:Jama Network Open

Tipo de trabajo:Estudio de cohortes

Extracto: AND RELEVANCE: In this cohort study of US veterans with incident IBD, incident use (vs nonuse) of TNF inhibitors was independently associated with higher risk of progressive eGFR decline but was not associated with risk of all-cause mortality. Further studies are needed to elucidate potentially distinct pathophysiologic contributions of TNF inhibitor use to kidney and nonkidney outcomes in patients with IBD.

Cita:JAMA Netw Open 2024 Apr 1; 7 (4) : e246822.

Autor/es:Sumida, Keiichi (a)
Shrestha, Prabin (b)

institución:(a) Division of Nephrology, Department of Medicine, University of Tennessee Health Science Center, Memphis.
(b) Division of Nephrology, Department of Medicine, University of Tennessee Health Science Center, Memphis.

Conflicto:Conflict of Interest Disclosures: Dr Kovesdy reported receiving personal fees from Abbott, Akebia, AstraZeneca, Bayer, Boehringer Ingelheim, Cara Therapeutics, CSL Vifor, GSK, Pharmacosmos, ProKidney, and Takeda outside the submitted work. No other disclosures were reported.

Formato:Informe virtual

Idioma:Inglés

País de fuente:EE.UU.

Sitio web:http://dx.doi.org/10.1001/jamanetworkopen.2024.6822

International journal of molecular sciences
Selección SIIC: 18 Abril, 2024
International journal of molecular sciences

Skin Autofluorescence as a Potential Adjunctive Marker for Cardiovascular Risk Assessment in Type 2 Diabetes

Skin Autofluorescence as a Potential Adjunctive Marker for Cardiovascular Risk Assessment in Type 2 Diabetes

Fuente:International Journal of Molecular Sciences

Tipo de trabajo:Revisión sistemática

Extracto: SAF levels are influenced by prolonged hyperglycemia, lifestyle, aging, and other chronic diseases such as depression, and it can be used as a predictive tool for CVE.

Claves:AGE, CV risk factors, SAF, T2DM

Cita:Int J Mol Sci 2024 Mar 31; 25 (7)

Autor/es:Reurean-Pintilei, Delia (a)
Pantea Stoian, Anca (b)

institución:(a) Doctoral School of Medicine and Pharmacy, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.
(b) Centre for Molecular Research in Nephrology and Vascular Disease, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.

Conflicto:Los autores declaran no tener conflictos de interés con la investigación

Formato:Informe virtual

Idioma:Inglés

País de fuente:Suiza

Sitio web:http://dx.doi.org/10.3390/ijms25073889

Selección SIIC: 18 Abril, 2024

IGF-1 and IGF-2 as Molecules Linked to Causes and Consequences of Obesity from Fetal Life to Adulthood

IGF-1 and IGF-2 as Molecules Linked to Causes and Consequences of Obesity from Fetal Life to Adulthood

Fuente:International Journal of Molecular Sciences

Tipo de trabajo:Revisión sistemática

Extracto: Imbalances in IGF levels are linked to a range of health conditions (e.g., insulin resistance, glucose intolerance, metabolic syndrome, and diabetes), prompting researchers to seek novel therapies and preventive strategies, offering challenges and opportunities in healthcare.

Claves:IGF-1, IGF-2, IGFs, cancer development, diabetes, metabolic syndrome, metabolic-associated fatty liver disease (MAFLD), obesity, pediatric obesity, puberty onset

Cita:Int J Mol Sci 2024 Apr 2; 25 (7)

Autor/es:Szydlowska-Gladysz, Justyna (a)
Gorecka, Adrianna Edyta (b)

institución:(a) Department of Pediatric Endocrinology and Diabetology with Endocrine-Metabolic Laboratory, Medical University in Lublin, 20-093 Lublin, Poland.
(b) Department of Pediatric Endocrinology and Diabetology with Endocrine-Metabolic Laboratory, Medical University in Lublin, 20-093 Lublin, Poland.

Conflicto:Los autores declaran no tener conflictos de interés con la investigación

Formato:Informe virtual

Idioma:Inglés

País de fuente:Suiza

Sitio web:http://dx.doi.org/10.3390/ijms25073966

Selección SIIC: 18 Abril, 2024

Prevalence of Selected Polymorphisms of Il7R, CD226, CAPSL, and CLEC16A Genes in Children and Adolescents with Autoimmune Thyroid Diseases.

Prevalence of Selected Polymorphisms of Il7R, CD226, CAPSL, and CLEC16A Genes in Children and Adolescents with Autoimmune Thyroid Diseases.

Fuente:International Journal of Molecular Sciences

Extracto: Similarly, the presence of the T allele in the CAPSL locus (rs1010601) seems to reduce the risk of HT development in all patients.

Claves:CAPSL, CD226, CLEC16A, Graves’ disease (GD), Hashimoto’s thyroiditis (HT), Il7R, autoimmune thyroid diseases (AITDs), children, genetic susceptibility, single-nucleotide polymorphism (SNP)

Cita:Int J Mol Sci 2024 Apr 4; 25 (7)

Autor/es:Borysewicz-Sańczyk, Hanna (a)
Wawrusiewicz-Kurylonek, Natalia (b)

institución:(a) Department of Pediatrics, Endocrinology, Diabetology with Cardiology Divisions, Medical University of Bialystok, J. Waszyngtona 17, 15-274 Bialystok, Poland.
(b) Department of Clinical Genetics, Medical University of Bialystok, J. Waszyngtona 13, 15-089 Bialystok, Poland.

Conflicto:Los autores declaran no tener conflictos de interés con la investigación

Formato:Informe virtual

Idioma:Inglés

País de fuente:Suiza

Sitio web:http://dx.doi.org/10.3390/ijms25074028

Selección SIIC: 18 Abril, 2024

Effect of Empagliflozin with or without the Addition of Evolocumab on HDL Subspecies in Individuals with Type 2 Diabetes Mellitus: A Post Hoc Analysis of the EXCEED-BHS3 Trial.

Effect of Empagliflozin with or without the Addition of Evolocumab on HDL Subspecies in Individuals with Type 2 Diabetes Mellitus: A Post Hoc Analysis of the EXCEED-BHS3 Trial.

Fuente:International Journal of Molecular Sciences

Extracto: The rise in smaller-sized HDL particles was heterogeneous amongst the treatment combinations.

Claves:PCSK9i, empagliflozin, evolocumab, high-density lipoprotein, type 2 diabetes mellitus

Cita:Int J Mol Sci 2024 Apr 8; 25 (7)

Autor/es:Bonilha, Isabella (a)
Gomes, Érica Ivana Lázaro (b)

institución:(a) Laboratory of Vascular Biology and Atherosclerosis (Aterolab), State University of Campinas (Unicamp), Sao Paulo 13083-887, Brazil.
(b) Laboratory of Vascular Biology and Atherosclerosis (Aterolab), State University of Campinas (Unicamp), Sao Paulo 13083-887, Brazil.

Conflicto:Los autores declaran no tener conflictos de interés con la investigación

Formato:Informe virtual

Idioma:Inglés

País de fuente:Suiza

Sitio web:http://dx.doi.org/10.3390/ijms25074108

Nutrients
Selección SIIC: 18 Abril, 2024
Nutrients

Chlorogenic Acid

Chlorogenic Acid

Fuente:Nutrients

Tipo de trabajo:Revisión sistemática

Extracto: Further studies for defining its specific targeting molecules, improving its bioavailability, and validating its clinical efficacy are required to corroborate the therapeutic effects of CGA.

Claves:AMPK, NF-kB, chlorogenic acid, chronic metabolic diseases, inflammation, metabolic homeostasis, neuromodulation, oxidation

Cita:Nutrients 2024 Mar 23; 16 (7)

Autor/es:Nguyen, Vi (a)
Taine, Elaine G (b)

institución:(a) Department of Cell Biology and Anatomy, School of Medicine, University of South Carolina, Columbia, SC 29209, USA.
(b) TritaliMed, Inc., Columbia, SC 29223, USA.

Conflicto:EGT is an employee of TritaliMed, Inc. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Formato:Informe virtual

Idioma:Inglés

País de fuente:Suiza

Sitio web:http://dx.doi.org/10.3390/nu16070924

Selección SIIC: 18 Abril, 2024

The Impact of Excessive Fructose Intake on Adipose Tissue and the Development of Childhood Obesity.

The Impact of Excessive Fructose Intake on Adipose Tissue and the Development of Childhood Obesity.

Fuente:Nutrients

Extracto: Consumers also need scientific education to understand potential health risks to themselves and their children.

Claves:adipose tissue, childhood obesity, fructose

Cita:Nutrients 2024 Mar 25; 16 (7)

Autor/es:Azevedo-Martins, Anna Karenina (a)
Santos, Matheus Pedro (b)

institución:(a) Group of Study in Endocrinology and Metabolism, School of Arts, Sciences and Humanities, University of São Paulo, São Paulo 03828-000, Brazil.
(b) Group of Study in Endocrinology and Metabolism, School of Arts, Sciences and Humanities, University of São Paulo, São Paulo 03828-000, Brazil.

Conflicto:Los autores declaran no tener conflictos de interés con la investigación

Formato:Informe virtual

Idioma:Inglés

País de fuente:Suiza

Sitio web:http://dx.doi.org/10.3390/nu16070939

Selección SIIC: 18 Abril, 2024

Effect of a Low-Calorie Dietary Intervention on Liver Health and Body Weight in Adults with Metabolic-Dysfunction Associated Steatotic Liver Disease (MASLD) and Overweight/Obesity

Effect of a Low-Calorie Dietary Intervention on Liver Health and Body Weight in Adults with Metabolic-Dysfunction Associated Steatotic Liver Disease (MASLD) and Overweight/Obesity

Fuente:Nutrients

Tipo de trabajo:Revisión sistemática

Extracto: In people with MASLD and obesity, an LCD intervention reduces IHL and body weight. Trials should focus on the recruitment of Black and Asian ethnicity participants.

Claves:MASLD, Very-Low-Calorie Diet, lifestyle medicine, obesity, overweight, randomised controlled trial, total-diet replacement

Cita:Nutrients 2024 Apr 1; 16 (7)

Autor/es:Dobbie, Laurence J (a)
Burgess, Jamie (b)

institución:(a) Department of Cardiovascular and Metabolic Medicine, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool L9 7AL, UK.
(b) Department of Diabetes & Endocrinology, Guys Hospital, Guy's and St Thomas' NHS Foundation Trust, London SE1 9RT, UK.

Conflicto:Los autores declaran no tener conflictos de interés con la investigación

Formato:Informe virtual

Idioma:Inglés

País de fuente:Suiza

Sitio web:http://dx.doi.org/10.3390/nu16071030

Selección SIIC: 18 Abril, 2024

Association between Daily Dietary Calcium Intake and the Risk of Cardiovascular Disease (CVD) in Postmenopausal Korean Women.

Association between Daily Dietary Calcium Intake and the Risk of Cardiovascular Disease (CVD) in Postmenopausal Korean Women.

Fuente:Nutrients

Extracto: Our findings suggest that a dietary calcium intake of >800 mg/day decreases the risk of CVD events in women who have been menopausal for >10 years.

Claves:Korea national health and nutrition examination survey (KNHANES), cardiovascular diseases, cross-sectional study, dietary calcium intake, menopause, postmenopausal women

Cita:Nutrients 2024 Apr 3; 16 (7)

Autor/es:Lee, Jae Kyung (a)
Tran, Thi Minh Chau (b)

institución:(a) Department of Obstetrics and Gynecology, Severance Hospital, Yonsei College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Republic of Korea.
(b) Department of Obstetrics and Gynecology, Tu Du Hospital, University of Medicine and Pharmacy, Ho Chi Minh City 700000, Vietnam.

Conflicto:Los autores declaran no tener conflictos de interés con la investigación

Formato:Informe virtual

Idioma:Inglés

País de fuente:Suiza

Sitio web:http://dx.doi.org/10.3390/nu16071043

Selección SIIC: 18 Abril, 2024

Improvement in Visceral Adipose Tissue and LDL Cholesterol by High PUFA Intake: 1-Year Results of the NutriAct Trial.

Improvement in Visceral Adipose Tissue and LDL Cholesterol by High PUFA Intake: 1-Year Results of the NutriAct Trial.

Fuente:Nutrients

Extracto: The NutriAct dietary pattern, particularly due to high PUFA content, effectively reduces VAT and cardiometabolic risk markers, independent of body weight loss.

Claves:LDL cholesterol, NutriAct, healthy aging, polyunsaturated fatty acid, visceral adipose tissue

Cita:Nutrients 2024 Apr 4; 16 (7)

Autor/es:Meyer, Nina Marie Tosca (a)
Pohrt, Anne (b)

institución:(a) Department of Endocrinology and Metabolism, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Charitéplatz 1, 10117 Berlin, Germany.
(b) NutriAct-Competence Cluster Nutrition Research Berlin-Potsdam, Arthur-Scheunert-Allee 114-116, 14558 Nuthetal, Germany.

Conflicto:L.P.B. was employed by Charité—Universitätsmedizin Berlin during the conduct of the study but as of 1st of August 2023 is employed by Novo Nordisk. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Formato:Informe virtual

Idioma:Inglés

País de fuente:Suiza

Sitio web:http://dx.doi.org/10.3390/nu16071057

Selección SIIC: 18 Abril, 2024

Diet and Physical Activity in Fabry Disease

Diet and Physical Activity in Fabry Disease

Fuente:Nutrients

Tipo de trabajo:Revisión

Extracto: Therefore, the aim of this review is to summarize current knowledge on the role of nutrition and physical activity in FD patients.

Claves:FODMAPs, Fabry disease, inflammation, nutritional therapy, oxidative stress, physical activity

Cita:Nutrients 2024 Apr 4; 16 (7)

Autor/es:Muscogiuri, Giovanna (a)
De Marco, Oriana (b)

institución:(a) Unità di Endocrinologia, Dipartimento di Medicina Clinica e Chirurgia, Diabetologia ed Andrologia, University of Naples Federico II, Via Sergio Pansini 5, 80131 Naples, Italy.
(b) Endocrinology Unit, Centro Italiano per la Cura e il Benessere del Paziente con Obesità (C.I.B.O), Department of Clinical Medicine and Surgery, University Medical School of Naples, Via Sergio Pansini 5, 80131 Naples, Italy.

Conflicto:Author Teodolinda Di Risi was employed by the Department of Public Health but collaborates on research with company CEINGE Biotecnologie Avanzate. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Formato:Informe virtual

Idioma:Inglés

País de fuente:Suiza

Sitio web:http://dx.doi.org/10.3390/nu16071061

BMC public health
Selección SIIC: 18 Abril, 2024
BMC public health

Novel anthropometric indices for predicting type 2 diabetes mellitus.

Novel anthropometric indices for predicting type 2 diabetes mellitus.

Fuente:Bmc Public Health

Extracto: The WHtR, BRI, VAI, and WHR outperformed other anthropometric indices in predicting T2DM in first-degree relatives (FDRs) of diabetic patients. However, further investigations in different populations may need to be implemented to justify their widespread adoption in clinical practice.

Claves:A body shape index, Anthropometric indices, Body adiposity index, Body mass index, Body roundness index, Diabetes mellitus, Diagnosis, Visceral adiposity index, Waist-to-height ratio, Waist-to-hip ratio

Cita:BMC Public Health 2024 Apr 13; 24 (1) : 1033.

Autor/es:Sadeghi, Erfan (a)
Khodadadiyan, Alireza (b)

institución:(a) Department of Biostatistics, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
(b) Department of Cardiovascular Research Centre, Shiraz University of Medical Sciences, Shiraz, Iran.

Conflicto:Los autores declaran no tener conflictos de interés con la investigación

Formato:Informe virtual

Idioma:Inglés

País de fuente:Reino Unido

Sitio web:http://dx.doi.org/10.1186/s12889-024-18541-7

Scientific reports
Selección SIIC: 18 Abril, 2024
Scientific reports

Transcriptomics analysis of long non-coding RNAs in smooth muscle cells from patients with peripheral artery disease and diabetes mellitus.

Transcriptomics analysis of long non-coding RNAs in smooth muscle cells from patients with peripheral artery disease and diabetes mellitus.

Fuente:Scientific Reports

Extracto: These lncRNAs might serve as potential therapeutic targets to improve the function of SMCs within the diseased tissue and, thus, the clinical outcome.

Cita:Sci Rep 2024 Apr 14; 14 (1) : 8615.

Autor/es:Yundung, Yankey (a)
Mohammed, Shafeeq (b)

institución:(a) Experimental Vascular Surgery/Department of Vascular Surgery, University Hospital Zurich/University of Zurich, Schlieren, Switzerland.
(b) Department of Cardiology/Center for Translational and Experimental Cardiology (CTEC), University Hospital Zurich/University of Zurich, Schlieren, Switzerland.

Conflicto:Los autores declaran no tener conflictos de interés con la investigación

Formato:Informe virtual

Idioma:Inglés

País de fuente:Reino Unido

Sitio web:http://dx.doi.org/10.1038/s41598-024-59164-7

BMC medical research methodology

Selección SIIC: 18 Abril, 2024

BMC medical research methodology

The potential impact fraction of population weight reduction scenarios on non-communicable diseases in Belgium: application of the g-computation approach.

The potential impact fraction of population weight reduction scenarios on non-communicable diseases in Belgium: application of the g-computation approach.

Fuente:Bmc Medical Research Methodology

Extracto: Implementing weight reduction scenarios among individuals with excess weight could lead to a substantial and statistically significant decrease in the prevalence of diabetes, hypertension, cardiovascular disease (CVD), and musculoskeletal (MSK) diseases in Belgium. The g-computation approach to assess PIF of interventions represents a straightforward approach for drawing causal inferences from observational data while providing useful information for policy makers.

Claves:Health impact assessment, Health policy, Non-communicable diseases, Overweight, Potential impact fractions, g-computation

Cita:BMC Med Res Methodol 2024 Apr 14; 24 (1) : 87.

Autor/es:Pelgrims, Ingrid (a)
Devleesschauwer, Brecht (b)

institución:(a) Department of Chemical and Physical Health Risks, Sciensano, Rue Juliette Wytsman 14, 1050, Brussels, Belgium. Ingrid.pelgrims@sciensano.be.
(b) Department of Applied Mathematics, Computer Science and Statistics, Ghent University, Krijgslaan 281, S9, BE-9000, Ghent, Belgium. Ingrid.pelgrims@sciensano.be.

Conflicto:Los autores declaran no tener conflictos de interés con la investigación

Formato:Informe virtual

Idioma:Inglés

País de fuente:Reino Unido

Sitio web:http://dx.doi.org/10.1186/s12874-024-02212-7

BMC public health
Selección SIIC: 18 Abril, 2024
BMC public health

Associations between cardiovascular diseases and cancer mortality: insights from a retrospective cohort analysis of NHANES data.

Associations between cardiovascular diseases and cancer mortality: insights from a retrospective cohort analysis of NHANES data.

Fuente:Bmc Public Health

Extracto: HF was associated with an increased risk of mortality from cancer, regardless of cancer history, while HBP, CHD and DM showed no significant association. These findings underscore the importance of understanding the mechanisms behind the increased risk of cancer mortality following HF.

Claves:Cancer mortality, Cardiovascular disease, Heart failure, National health and nutrition examination survey

Cita:BMC Public Health 2024 Apr 15; 24 (1) : 1049.

Autor/es:Ge, Chenliang (a)
Jiang, Zhiyuan (b)

institución:(a) Department of Cardiology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, China.
(b) Department of Cardiology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, China.

Conflicto:Los autores declaran no tener conflictos de interés con la investigación

Formato:Informe virtual

Idioma:Inglés

País de fuente:Reino Unido

Sitio web:http://dx.doi.org/10.1186/s12889-024-18498-7

Cardiovascular diabetology
Selección SIIC: 18 Abril, 2024
Cardiovascular diabetology

Risk factors for and risk of all-cause and atherosclerotic cardiovascular disease mortality in people with type 2 diabetes and peripheral artery disease

Risk factors for and risk of all-cause and atherosclerotic cardiovascular disease mortality in people with type 2 diabetes and peripheral artery disease

Fuente:Cardiovascular Diabetology

Tipo de trabajo:Estudio de cohortes

Extracto: The presence of T2D with concomitant PAD is related to an increased risk of both all-cause and cardiovascular mortality compared with individuals with only PAD. This argues for implementing optimized and intensive treatment strategies for individuals with both conditions.

Claves:All-cause mortality, Cardiovascular mortality, Cardiovascular risk factors, Cohort study, Observational study, Peripheral artery disease, Type 2 diabetes mellitus

Cita:Cardiovasc Diabetol 2024 Apr 15; 23 (1) : 127.

Autor/es:Avdic, Tarik (a)
Carlsen, Hanne K (b)

institución:(a) Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Medicinaregatan 18G, Gothenburg, 413 45, Sweden. tarik.avdic@gu.se.
(b) Department of Internal Medicine, Sahlgrenska University Hospital/Östra, Gothenburg, Sweden. tarik.avdic@gu.se.

Conflicto:Los autores declaran no tener conflictos de interés con la investigación

Formato:Informe virtual

Idioma:Inglés

País de fuente:Reino Unido

Sitio web:http://dx.doi.org/10.1186/s12933-024-02226-x

BMC public health
Selección SIIC: 18 Abril, 2024
BMC public health

Correlation of pre-existing comorbidities with disease severity in individuals infected with SARS-COV-2 virus.

Correlation of pre-existing comorbidities with disease severity in individuals infected with SARS-COV-2 virus.

Fuente:Bmc Public Health

Extracto: Our study has shown that comorbidities such as urinary system diseases and cardiovascular diseases tend to have a negative impact on Covid-19, leading to a poor outcome resulting in death, while diabetes mellitus and hypertension have an impact but without statistical significance.

Claves:Cardiovascular diseases, Comorbidities, Diabetes mellitus, Hypertension, Urinary system diseases

Cita:BMC Public Health 2024 Apr 15; 24 (1) : 1053.

Autor/es:Marušić, Jasmina (a)
Hasković, Edhem (b)

institución:(a) Department of Health Care, Faculty of Medicine, University of Zenica, Zenica, Bosnia and Herzegovina. jasminavele@gmail.com.
(b) Marjanovića put 39, 72000, Zenica, Bosnia and Herzegovina. jasminavele@gmail.com.

Conflicto:Los autores declaran no tener conflictos de interés con la investigación

Formato:Informe virtual

Idioma:Inglés

País de fuente:Reino Unido

Sitio web:http://dx.doi.org/10.1186/s12889-024-18457-2

Diabetes & vascular disease research
Selección SIIC: 18 Abril, 2024
Diabetes & vascular disease research

Diabetes mellitus does not alter mortality or hospitalisation risk in patients with newly diagnosed heart failure with preserved ejection fraction: Time to rethink pathophysiological models of disease progression.

Diabetes mellitus does not alter mortality or hospitalisation risk in patients with newly diagnosed heart failure with preserved ejection fraction: Time to rethink pathophysiological models of disease progression.

Fuente:Diabetes & Vascular Disease Research

Tipo de trabajo:Estudio de cohortes

Extracto: In unselected patients with newly diagnosed HF, diabetes is not an adverse prognostic marker in patients with HFpEF, but is in HFrEF.

Claves:Heart failure, diabetes, ejection fraction, mortality, preserved

Cita:Diab Vasc Dis Res 2024 Mar-Apr; 21 (2) : 14791641231224241.

Autor/es:Gierula, John (a)
Straw, Sam (b)

institución:(a) Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK. RINGGOLD: 573267
(b) Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK. RINGGOLD: 573267

Conflicto:Declaration of conflicting interestsThe author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: John Gierula has received speaker fees from Abbott and Medtronic and consultancy fees from Microport. Klaus Witte has received speaker fees from Medtronic, Microport, Abbott, Cardiac Dimensions, Pfizer, Bayer, and Bristol-Myers Squibb. Peter Grant has received speaker... masnoticias.gif

Formato:Informe impreso

Idioma:Inglés

País de fuente:Reino Unido

Sitio web:http://dx.doi.org/10.1177/14791641231224241

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18  19 20 Avanza 20 páginas